$CTIC Recent Headlines Insider filings one way to track

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2013 at 9:56 AM

$CTIC Recent Headlines

Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com

BlackBerry Gets Downgraded, Vanda’s Meteoric Rise, and 3 More Hot Stocks 1:53 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Bank of America Disallows Online Gambling Transactions and 2 Other Hot Stocks to Watch 11:32 a.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Baxter, Cell Therapeutics Sign Licensing Agreement 9:18 a.m. Nov. 15, 2013 - WSJ.com
Will the New Arthritis Drug Help Celgene Surge Higher? 7:05 p.m. Nov. 9, 2013 - Wall St. Cheat Sheet
9 Biotechnology Stocks to Sell Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Deal Or No Deal: Hedge Funds Like These 6 Small Cap Stocks Under 5 Dollars 4:52 p.m. Nov. 5, 2013 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, BP, Gap, Teva and More 7:41 a.m. Nov. 4, 2013 - 247WallSt.com
Cell Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript 11:50 p.m. Oct. 30, 2013 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:20 p.m. Oct. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Oct. 30, 2013 - Seeking Alpha
2 Speculative Biotechs For The 'Shotgun Investor' 11:12 a.m. Oct. 29, 2013 - Seeking Alpha
Will Celgene Continue to Trade at All-Time Highs? 6:19 p.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Interesting CTIC Put And Call Options For June 2014 10:53 a.m. Oct. 23, 2013 - TheStreet.com
Cell Therapeutics Announces Results from Preclinical Study of Pixantrone at AACR-NCI-EORTC Conference 5:26 a.m. Oct. 21, 2013 - benzinga.com
Cell Therapeutics Must Deliver on Promise for Myelofibrosis Drug Partner 8:14 a.m. Oct. 8, 2013 - TheStreet.com
Zynga Founder Is Bored With Games and 2 More Heavily Traded Stocks to Follow 4:58 p.m. Oct. 7, 2013 - Wall St. Cheat Sheet
Cell Therapeutics Reaches Agreement with FDA on SPA for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis 4:56 a.m. Oct. 7, 2013 - benzinga.com
Cell Therapeutics: Sell Now, Ask Questions Later... Again 6:22 p.m. Sept. 29, 2013 - Seeking Alpha
First Week Of November 16th Options Trading For Cell Therapeutics (CTIC) 2:04 p.m. Sept. 26, 2013 - TheStreet.com
10 Biotechnology Stocks to Sell Now 5:45 a.m. Sept. 4, 2013 - InvestorPlace.com

CTIC, TTS, EGHT and ICLD to NASDAQ Active Stock Watch List at EPR 10:12 a.m. Nov. 15, 2013 - ACCESSWIRE
Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership 7:36 a.m. Nov. 15, 2013 - PR Newswire
Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib 7:30 a.m. Nov. 15, 2013 - BusinessWire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
CTI Announces Data Presentations at the 55th American Society of Hematology Annual Meeting 4:00 p.m. Nov. 7, 2013 - PR Newswire
M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell Therapeutics 8:46 a.m. Nov. 6, 2013 - PR Newswire
Cell Therapeutics Reports Third Quarter 2013 Financial Results 3:00 p.m. Oct. 30, 2013 - PR Newswire
Cell Therapeutics to Report Third Quarter Financial Results after Market on October 30, 2013 12:30 a.m. Oct. 23, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:05 a.m. Oct. 21, 2013 - PR Newswire
Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting 12:30 a.m. Oct. 21, 2013 - PR Newswire
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) 12:30 a.m. Oct. 15, 2013 - PR Newswire
Cell Therapeutics Adds Three Leaders in Blood Cancer Research and Development to Scientific Advisory Board 12:30 a.m. Oct. 14, 2013 - PR Newswire
Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda 7:00 a.m. Oct. 10, 2013 - PR Newswire
Cell Therapeutics Announces Agreement with the FDA on Special Protocol Assessment for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis 12:30 a.m. Oct. 7, 2013 - PR Newswire
Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. 7:52 a.m. Sept. 25, 2013 - PR Newswire
Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock 12:30 a.m. Sept. 19, 2013 - PR Newswire
Cell Therapeutics Announces Sale of Convertible Preferred Stock 12:30 a.m. Sept. 13, 2013 - PR Newswire
Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:21 a.m. Aug. 19, 2013 - PR Newswire
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) 12:30 a.m. Aug. 19, 2013 - PR Newswire
Cell Therapeutics Reports Second Quarter 2013 Financial Results 3:00 p.m. July 31, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Instanodes Tackling Quantum Threats in Blockchain

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Yunji Rolls Out AI Robots at EquipHotel Paris 2026

AI Takes Center Stage in Hospitality When someone mentions a new revolution in hospitality, I usually roll my eyes. But this time, Yunji Technology (HKEX: 02670) is bringing something to the table that's hard to ignore. They’re out in full force at EquipHotel Paris 2026, flaunting their AI-powered collection of service bots with the kind of confidence that says, 'We're...

Syra Health Hits Record Revenue, Sustains Growth

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Marathon Petroleum's Massive Q3 2026 Profit Surge

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Chunghwa's Q3 2026 Results Show Revenue and Profit Boom

Revenue Rises Beyond Expectations Well, if there's ever a time to keep your telecom stocks in your sight, it's right now with Chunghwa Telecom. They just rolled out their unaudited Q3 2026 results, and it's like a firework show of numbers—lighting up the sky with a whopping revenue increase by 16.7% to NT$ 67.59 billion. Whatever they're feeding their cash registers...

LUX Infusion Expands in Nebraska with New Acquisitions

Strategic Expansion: LUX Infusion's Bold Move When it comes to healthcare, it's often about pulling the right strings at the right time, and today, LUX Infusion's got their timing spot on. They've swooped in with a savvy acquisition, taking over two key specialty infusion centers in Lincoln and Omaha. This isn't just a pencil-pusher's cynical corporate move; it's a push...

Meiyume Unveils Futuristic Beauty Experience at Event

Turning Heads in the World of Beauty Let's dive into the vibrant world of beauty innovation, where Meiyume's latest showcase at Cosmopack Asia 2026 has been the talk of the town. Located at Booth 3-C01, Meiyume introduced BEACON, a revolutionary experience that aims to guide brands in spotting market opportunities and realizing them through a connected global ecosystem....

Staypineapple Backs Vets: A Heartwarming Initiative

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Orlando's Holiday Extravaganza: Theme Parks to Unique Festivities

Holiday Cheer Abounds in Orlando Orlando's never a letdown when it comes to spectacle, but this holiday season, they've taken it up a notch and a half. The city's bursting with festivities, from the iconic theme parks to lively local events that offer something for everyone. Whether you're entertaining kids or looking for grown-up glitz, Orlando's got you sorted. Merry...

Edible Oils: Market Growth, Trends, and Investments

Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...